medroxyprogesterone acetate has been researched along with Recrudescence in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (23.08) | 18.7374 |
| 1990's | 10 (25.64) | 18.2507 |
| 2000's | 6 (15.38) | 29.6817 |
| 2010's | 13 (33.33) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Di Guardo, F; Palumbo, M | 1 |
| Kajiyama, H; Kikkawa, F; Mizuno, M; Niimi, K; Sakata, J; Shibata, K; Suzuki, S; Tamauchi, S; Utsumi, F | 1 |
| Cheewadhanaraks, S | 1 |
| Banda, K; Bunce, CM; Drayson, MT; Dunn, JA; Iqbal, G; Khanim, FL; Merrick, B; Molyneux, E | 1 |
| Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y | 1 |
| Arnes, M; Straume, B; Vereide, AB; Ørbo, A | 1 |
| Aoki, D; Banno, K; Hamatani, T; Hirasawa, A; Inoue, O; Kuji, N; Ogawa, S; Susumu, N; Takemoto, T; Tanaka, M; Yamagami, W | 1 |
| Buchta, V; Jílek, P; Kestřánek, J; Leško, D; Plucnarová, S; Špaček, J | 1 |
| Bhattacharya, S; Daniels, JP; Middleton, LJ; Weckesser, A | 1 |
| Al Kadri, H; Al-Fozan, HM; Hajeer, A; Hassan, S | 1 |
| Abbiati, A; Barbara, G; Fedele, L; Somigliana, E; Vercellini, P; Viganò, P | 1 |
| Bunce, CM; Craddock, CF; Drayson, MT; Hayden, RE; Holyoake, TL; Jackson, N; Khanim, FL; Lumley, M; Murray, JA | 1 |
| Koyanagi, T; Kuromatsu, H; Miyabe, K; Nishio, S | 1 |
| Mizuno, M; Nakanishi, T; Nawa, A; Yatabe, Y | 1 |
| Kusama, M | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Lee, SH; Nam, JH; Park, JY; Seong, SJ | 1 |
| Berger, RE | 1 |
| Boyd, NR; Moazzami, B; Van der Walt, JD | 1 |
| Boyce, SW; Hoffman, PG; Mathes, SJ | 1 |
| Cavanaugh, JL; Haywood, TW; Kelly, J; Kravitz, HM; Liles, S; Wahlstrom, C | 1 |
| Anderström, C; Eddeland, A; Folmerz, P; Hansson, R; Milles, S; Zachrisson, B | 1 |
| Grimes, DA | 1 |
| Cavanaugh, JL; Haywood, TW; Kelly, J; Kravitz, HM; Liles, S | 1 |
| Calmon, LC; Coutinho, EM; Maia, H; Marques, D | 1 |
| Lunn, M | 1 |
| Adelson, MD; Alvarez, RD; Brady, MF; Given, FT; Homesley, HD; Manetta, A; Soper, JT; Thigpen, JT | 1 |
| Barrett-Connor, E; Hulley, SB; Knopp, RH; Levy, RI; Lin, F; Shlipak, MG; Simon, JA; Vittinghoff, E | 1 |
| Baba, K; Fukuda, M; Hamamoto, R; Matsuda, M; Matsuoka, Y; Miyayama, H; Mizumoto, T; Nagao, K; Nishimura, R; Yamashita, H | 1 |
| Rice, VM | 1 |
| Cole, C; Emory, E; Meyer, WJ | 1 |
| Cooper, L; Hart, BL | 1 |
| Broux, R; Corhay, JL; Limet, R; Radermecker, M | 1 |
| Altaras, MM; Bloch, B; Cloete, K; Goldberg, GL; Wiswedel, K | 1 |
| Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H | 1 |
| Dmowski, WP; Radwanska, E; Rana, N | 1 |
| Dennerstein, GJ | 1 |
| Barnhill, D; Burke, T; Heller, P; Hoskins, W; Park, R; Weiser, E | 1 |
| Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F | 1 |
| Presl, J | 1 |
3 review(s) available for medroxyprogesterone acetate and Recrudescence
| Article | Year |
|---|---|
Hormone therapy for endometriosis and surgical menopause.
Topics: Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause, Premature; Norpregnenes; Pain; Postoperative Complications; Progesterone; Randomized Controlled Trials as Topic; Recurrence | 2009 |
Repetitive surgery for recurrent symptomatic endometriosis: what to do?
Topics: Adult; Danazol; Endometriosis; Female; Humans; Hysterectomy; Ligaments; Medroxyprogesterone Acetate; Ovariectomy; Pelvic Pain; Postoperative Care; Recurrence; Reoperation | 2009 |
Conventional medical therapies for endometriosis.
Topics: Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Medroxyprogesterone Acetate; Recurrence | 2002 |
10 trial(s) available for medroxyprogesterone acetate and Recrudescence
| Article | Year |
|---|---|
Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Burkitt Lymphoma; Child; Child, Preschool; Drug Resistance, Neoplasm; Endemic Diseases; Female; Humans; Malawi; Male; Medroxyprogesterone Acetate; Recurrence | 2014 |
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Recurrence | 2016 |
Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitme
Topics: Adolescent; Adult; Clinical Protocols; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Endometriosis; Feasibility Studies; Female; Humans; Injections; Intrauterine Devices; Laparoscopy; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Patient Selection; Pilot Projects; Progestins; Recurrence; Research Design; Secondary Prevention; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2017 |
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Female; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Treatment Outcome | 2010 |
Medroxyprogesterone treatment for paraphiliacs.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Child Abuse, Sexual; Criminal Law; Humans; Imagination; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Middle Aged; Paraphilic Disorders; Patient Compliance; Recurrence; Self Disclosure; Sexual Behavior; Surveys and Questionnaires; Testosterone; Time Factors | 1995 |
Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Estramustine; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Recurrence | 1995 |
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Receptors, Progesterone; Recurrence; Survival Rate; Treatment Outcome | 1999 |
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
Topics: Aged; Coronary Disease; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Proportional Hazards Models; Recurrence; Risk Factors | 2000 |
Comparison of diazepam with progestin for effectiveness in suppression of urine spraying behavior in cats.
Topics: Animals; Appetite; Ataxia; Behavior, Animal; Cat Diseases; Cats; Diazepam; Female; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progestins; Recurrence; Sleep; Urination Disorders; Weight Gain | 1992 |
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence | 1988 |
26 other study(ies) available for medroxyprogesterone acetate and Recrudescence
| Article | Year |
|---|---|
Asherman syndrome and insufficient endometrial thickness: A hypothesis of integrated approach to restore the endometrium.
Topics: Combined Modality Therapy; Drug Therapy, Combination; Endometrium; Estradiol; Female; Gynatresia; Humans; Hysteroscopy; Infertility, Female; Medroxyprogesterone Acetate; Postoperative Complications; Pregnancy; Pregnancy Rate; Recurrence; Side-Population Cells; Tissue Adhesions | 2020 |
Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Recurrence | 2018 |
Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate therapy.
Topics: Adult; Delayed-Action Preparations; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Recurrence | 2013 |
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Logistic Models; Medroxyprogesterone Acetate; Multivariate Analysis; Odds Ratio; Pregnancy; Pregnancy Outcome; Recurrence; Retrospective Studies; Risk Factors | 2016 |
Comparison of two long-term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Disease Management; Female; Humans; Medroxyprogesterone Acetate; Pilot Projects; Progestins; Prospective Studies; Quality of Life; Recurrence; Time; Visual Analog Scale; Young Adult | 2017 |
[Two cases of multidrug-resistant recurrent endometrial cancer successfully treated with medroxyprogesterone acetate (MPA)].
Topics: Aged; Antineoplastic Agents, Hormonal; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Tomography, X-Ray Computed | 2010 |
Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Sarcoma, Endometrial Stromal; Survival Analysis; Uterine Neoplasms | 2012 |
[Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Pleural Neoplasms; Quality of Life; Recurrence; Thoracic Wall | 2012 |
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Recurrence | 2013 |
Urinary tract infection in the users of depot-medroxyprogesterone acetate.
Topics: Adult; Case-Control Studies; Cohort Studies; Coitus Interruptus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Iran; Long-Term Care; Medroxyprogesterone Acetate; Recurrence; Risk; Statistics as Topic; Urinary Tract Infections | 2005 |
Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus.
Topics: Adenocarcinoma; Adult; Aged; Castration; Female; Gestonorone Caproate; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Postoperative Period; Recurrence; Uterine Neoplasms | 1983 |
Recurrent macromastia after subcutaneous mastectomy.
Topics: Adult; Breast; Breast Diseases; Combined Modality Therapy; Dydrogesterone; Female; Humans; Hypertrophy; Immunosuppressive Agents; Mastectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Recurrence; Reoperation; Surgery, Plastic; Tamoxifen | 1984 |
A 17-year-old mother seeking contraception.
Topics: Adolescent; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Decision Making; Family Planning Services; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Compliance; Patient Education as Topic; Pregnancy; Pregnancy in Adolescence; Recurrence; Sexually Transmitted Diseases; Single Parent | 1996 |
Medroxyprogesterone and paraphiles: do testosterone levels matter?
Topics: Age Factors; Humans; Male; Medroxyprogesterone Acetate; Paraphilic Disorders; Recurrence; Regression Analysis; Sexual Behavior; Socioeconomic Factors; Statistics, Nonparametric; Survival Analysis; Testosterone; Treatment Outcome | 1996 |
Administration of medroxyprogesterone acetate after endomyometrial resection.
Topics: Adult; Biopsy; Endometrium; Female; Follow-Up Studies; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Postoperative Care; Postoperative Complications; Progesterone Congeners; Recurrence; Retrospective Studies | 1997 |
Applying k-sample tests to conditional probabilities for competing risks in a clinical trial.
Topics: Antineoplastic Agents, Hormonal; Biometry; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Probability; Prognosis; Randomized Controlled Trials as Topic; Receptors, Estrogen; Recurrence; Risk Factors; Tamoxifen; Treatment Failure | 1998 |
An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Outcome Assessment, Health Care; Recurrence | 2000 |
Depo provera treatment for sex offending behavior: an evaluation of outcome.
Topics: Adolescent; Adult; Aged; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Paraphilic Disorders; Personality Disorders; Radioimmunoassay; Recurrence; Sex Offenses; Sexual Behavior; Testosterone; Treatment Outcome | 1992 |
Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pneumothorax; Recurrence; Tamoxifen | 1992 |
Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
Topics: Adolescent; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Peptide Fragments; Pregnancy; Prospective Studies; Recurrence; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain | 1989 |
Recurrent endometriosis following hysterectomy and oophorectomy: the role of residual ovarian fragments.
Topics: Adult; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypertrophy; Hysterectomy; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovariectomy; Ovary; Postoperative Complications; Recurrence | 1988 |
Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.
Topics: Adult; Candidiasis; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Recurrence; Vaginal Diseases; Vulvar Diseases | 1986 |
The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate.
Topics: Adult; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications; Puerperal Disorders; Recurrence; Retroperitoneal Fibrosis | 1987 |
[Medroxyprogesterone acetate in the treatment of recurrent vaginal candidiasis].
Topics: Candidiasis, Vulvovaginal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Recurrence | 1988 |